2021
DOI: 10.1111/jcmm.16543
|View full text |Cite
|
Sign up to set email alerts
|

Transforming growth factor‐β1 signalling triggers vascular endothelial growth factor resistance and monocyte dysfunction in type 2 diabetes mellitus

Abstract: Type 2 diabetes mellitus (T2DM) is one of the main risk factors for the development of atherosclerosis. Moreover, the formation of collateral arteries is decreased in patients with T2DM. 1,2 Monocytes play an important role in vascular biology during angiogenesis and arteriogenesis including the development of collateral vessels following coronary artery occlusion. 3,4 Any imbalance of number or function of monocytes has detrimental consequences for vascular healing and may lead to cardiovascular pathology suc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Although the evidence about the expression of Col I and VEGF in hyperglycemia-induced tendon damage is controversial, 23 , 71 , 81 , 82 our results are in line with the reduction of Col I and neoangiogenesis reported in preclinical and clinical settings of diabetic tendinopathy. 21 , 81 , 83 85 The TGF-β1 related effects in diabetes 51 , 74 , 81 , 86 89 on the levels of Col I, the main component of tendon dry mass 90 and of VEGF, the most important angiogenic factor involved in tendon healing, 91 support the potential role of TGF-β released by ASC-CM in improving tenocytes mediated tendon healing process under HG stimulus.…”
Section: Discussionmentioning
confidence: 86%
“…Although the evidence about the expression of Col I and VEGF in hyperglycemia-induced tendon damage is controversial, 23 , 71 , 81 , 82 our results are in line with the reduction of Col I and neoangiogenesis reported in preclinical and clinical settings of diabetic tendinopathy. 21 , 81 , 83 85 The TGF-β1 related effects in diabetes 51 , 74 , 81 , 86 89 on the levels of Col I, the main component of tendon dry mass 90 and of VEGF, the most important angiogenic factor involved in tendon healing, 91 support the potential role of TGF-β released by ASC-CM in improving tenocytes mediated tendon healing process under HG stimulus.…”
Section: Discussionmentioning
confidence: 86%
“…After the determination of mRNA expression, VEGFA, KDR, MAPK14, and PPARA were verified to be the effective targets. In T2DM patients, the expression of soluble VEGF-receptor 1 was increased in monocytes under high-glucose conditions, which inhibited VEGF signaling ( Makowski et al, 2021 ). VEGF resistance was a molecular concept that caused cellular dysfunction in diabetes mellitus ( Tchaikovski et al, 2009 ).…”
Section: Discussionmentioning
confidence: 99%
“…T2DM leads to increased TGFβ signaling, which interferes with VEGFA-induced monocyte migration and leads to monocyte dysfunction. TGFβ signaling can affect monocyte function, causing vascular complications [ 43 ] in T2DM patients. Studies have found that serum TGF-β1 levels in patients with Alzheimer’s disease (AD), vascular dementia (VaD), and Parkinson’s disease dementia (PDD) are significantly increased, but serum TGF-β1 levels in AD and VaD are significantly higher than those in PDD [ 44 ].…”
Section: Discussionmentioning
confidence: 99%